老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
KraneShares MSCI All China Health Care Index ETF
18.36
+0.0793
0.43%
盤後：
18.30
-0.0588
-0.32%
19:30 EDT
成交量：
3.00萬
成交額：
54.97萬
市值：
1.08億
市盈率：
- -
高：
18.43
開：
18.31
低：
18.20
收：
18.28
52周最高：
21.50
52周最低：
14.38
股本：
590.02萬
流通股本：
590.02萬
量比：
1.09
換手率：
0.51%
股息：
0.71
股息率：
3.89%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
智通港股解盤 | 美國放緩AI另有玄機 WCLC大會再度催化創新藥
智通财经
·
09/14
北水動向|北水成交淨買入44.71億 北水逢低加倉AI硬件股 全天搶籌智譜(02513)超12億港元
智通财经
·
09/14
石藥集團(01093.HK)：SYS 6010聯合恩朗蘇拜單抗用於治療未經系統性治療的驅動基因陰性晚期NSCLC的I / II期臨床研究數據於2026年世界肺癌大會(WCLC)上以口頭報告形式公布
智通财经
·
09/14
百濟神州員工購股計劃完成購買812,149股 涉及4,590名員工
同花顺
·
09/14
百濟神州(06160.HK)：合共6.25萬股美國存托股份由4590名參與者根據2018員工購股計劃購買
智通财经
·
09/14
大行評級丨傑富瑞：康方生物依沃西單抗H-2研究取得正面結果，維持「買入」評級
格隆汇
·
09/14
小摩：康方生物(09926.HK)HARMONi-2總生存期數據強勁 維持「增持」評級
智通财经
·
09/14
信達生物(01801)出現大手買入6.45萬股，成交價$96.65，涉資623.392萬
阿斯达克财经
·
09/14
《大行》富瑞：康方生物(09926.HK)依沃西單抗單藥總生存期數據良好
阿斯达克财经
·
09/14
藥明生物(02269)股價上升5.021%，現價港幣$49.36
阿斯达克财经
·
09/14
港股異動 | 創新藥概念股全線走高 WCLC臨床數據重磅催化 機構指回調後配置價值凸顯
智通财经
·
09/14
港股異動 | CRO概念股漲幅居前、凱萊英大漲12%，中報持續驗證行業高景氣，多家公司上調業績指引
智通财经
·
09/14
大行評級丨花旗：維持康方生物「買入」評級，HARMONi-2總生存期優效強化ivonescimab差異化優勢
格隆汇
·
09/14
港股早盤低開高走 恒生指數半日上漲0.35% 藥明生物（02269）漲4.81%
金吾财讯
·
09/14
《大行》花旗：康方生物(09926.HK)HARMONi-2總生存期優效強化ivonescimab差異化優勢
阿斯达克财经
·
09/14
康方生物(09926.HK)升近半成 里昂：Harmoni-2總生存期更新正面
阿斯达克财经
·
09/14
港股異動丨康方生物漲近7%，依沃西試驗生存期超過默沙東競品
格隆汇
·
09/14
醫藥板塊表現強勢 凱萊英（06821）升逾5% 機構制AI製藥商業化風口初步顯現
金吾财讯
·
09/14
康方生物港股走高 其依沃西單藥在試驗中的總生存期超過默沙東競品
南方财经网
·
09/14
康方生物(09926)出現大手賣出6.4萬股，成交價$90.0，涉資576萬
阿斯达克财经
·
09/14
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/KURE/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.3593,"timestamp":1789761600000,"preClose":18.28,"halted":0,"volume":30007,"hourTrading":{"tag":"盘后","latestPrice":18.3005,"preClose":18.3593,"latestTime":"19:30 EDT","volume":9,"amount":164.8058,"timestamp":1789774205135,"change":-0.0588,"changeRate":-0.003203,"amplitude":0},"delay":0,"changeRate":0.004338074398249449,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"休市中","change":0.0793,"latestTime":"09-18 16:00:00 EDT","open":18.31,"high":18.4299,"low":18.2,"amount":549746.6642979999,"amplitude":0.012577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.28,"sharesOutstanding":4750002,"nav":18.2,"aum":106490719.49,"dividendRate":0.038934,"bidAskSpread":0.011872,"postHourTrading":{"tag":"盘后","latestPrice":18.3005,"preClose":18.3593,"latestTime":"19:30 EDT","volume":9,"amount":164.8058,"timestamp":1789774205135,"change":-0.0588,"changeRate":-0.003203,"amplitude":0},"volumeRatio":1.0912112465055275,"impliedVol":0.1722,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0912112465055275,"shares":5900168,"dividePrice":0.7148,"high":18.4299,"amplitude":0.012577,"preClose":18.28,"low":18.2,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":18.3593,"eps":0,"divideRate":0.038934,"volume":30007,"delay":0,"ttmEps":0,"open":18.31,"prevYearClose":17.04,"prevWeekClose":17.74,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":17.74,"twentyDayClose":19.34,"sixtyDayClose":15.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667666143","title":"智通港股解盤 | 美國放緩AI另有玄機 WCLC大會再度催化創新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666143?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 20:45","pubTimestamp":1789389921,"startTime":"0","endTime":"0","summary":"科技股的走弱，和 Anthropic、OpenAI 与 SpaceX 罕见联手集体呼吁放缓AI 开发步伐有关。业绩方面，多光谱 AI 大模型服务收入冲到 3.20 亿元，同比暴涨 382.5%，收入占比直接从 29.8% 飙升至 78%。机构认为，2026 年 WCLC 大会的主角仍是 IO2.0 与 ADC，肺癌领域尤其是 1L 非小细胞肺癌的标准治疗范式正处于迭代前夜，国产双抗与 ADC 的进度全球领先。授权品种的里程碑付款与商业化分成，正在成为创新药企业价值兑现的第二曲线。这是公司首款双抗 ADC 获批临床，也是公司第三款 ADC 创新药进入临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1566","LU0348735423.USD","LU1808992512.USD","06160","LU0307460666.USD","LU0877626530.USD","IE00BZ08YS42.EUR","AGIX","06978","LU1051768304.USD","IE00B543WZ88.USD","LU0640798160.USD","IE00BPRC5H50.USD","BK1500","LU0431992006.USD","LU0821914370.USD","LNGR","QTOC","IE00BZ08YR35.GBP","VTHR","LU1969619763.USD","VXUS","BK1161","09969","IE0034224299.USD","AIPO","IE00BGHQDM52.EUR","01193","CHAT","LU0593848301.USD","IE00B29SXG58.USD","KCAI","IE00BZ08YT58.USD","IE0008369823.USD","KURE","BK1574","IBBQ","BK1521","LU0651946864.USD","06690","00135","ARTY","02688","MEDX","BK4588","159992","LU1515016050.SGD","IE00BMCWC346.EUR","LU1224709979.USD","LU0287142896.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667652997","title":"北水動向|北水成交淨買入44.71億 北水逢低加倉AI硬件股 全天搶籌智譜(02513)超12億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667652997","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667652997?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:46","pubTimestamp":1789379185,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月14日港股市场，北水成交净买入44.71亿港元。北水净买入最多的个股是智谱、长飞光纤光缆、联想集团。港股通(沪)活跃成交股港股通(深)活跃成交股智谱获净买入12.01亿港元。浙商证券指出，该事件短期使AI硬件公司，大模型公司承压。康方生物、药明生物分别获净买入1.04亿、1385万港元。随新旗舰产品推出，该行认为小米收入及盈利应于2026年第三季见底，并于第四季开始反弹。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0972618739.USD","LU0052756011.USD","CHAT","LNVGY","LU0348825331.USD","00992","LU0264606111.USD","LU0862451837.USD","LU0049112450.USD","HK0000320223.HKD","BK1161","BK1193","IE0034224299.USD","LU0029875118.USD","LU0561508036.HKD","02513","LU1961090484.USD","LU0307460666.USD","KURE","80992","AIPO","LU1046422090.SGD","BK1117","BK1506","HK0000306685.HKD","ARTY","LU0588546209.SGD","LU0634319403.HKD","LU0348735423.USD","LU1785774172.SGD","HK0000306701.USD","IE00BPRC5H50.USD","LU0310800965.SGD","LU0890818403.SGD","LU0417516738.SGD","IE00B0JY6N72.USD","LU0048580855.USD","LU0128525689.USD","06869","BK1574","09926","AGIX","VTHR","QTOC","HK0000320264.USD","LU0672654166.SGD","LU1206782309.USD","SG9999006597.SGD","IE00B5MMRT66.SGD","TCHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667269654","title":"石藥集團(01093.HK)：SYS 6010聯合恩朗蘇拜單抗用於治療未經系統性治療的驅動基因陰性晚期NSCLC的I / II期臨床研究數據於2026年世界肺癌大會(WCLC)上以口頭報告形式公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2667269654","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667269654?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:34","pubTimestamp":1789378468,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ08YT58.USD","IE0008368742.USD","LU0072913022.USD","LU1152091168.USD","LU1813983027.USD","KURE","LU0067412154.USD","IE0008369823.USD","SG9999004220.SGD","BK1191","IE00B031HY20.USD","LU0315179316.USD","01093","LU1807302812.USD","LU1152091754.HKD","LU1951186391.HKD","LU1960683339.HKD","IE00B543WZ88.USD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU1226288253.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU0501845795.SGD","LU0880133367.SGD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00BZ08YS42.EUR","BK1521","LU1008478684.HKD","LU1226287875.USD","LU1226288170.HKD","LU0314109678.HKD","LU0140636845.USD","BK1515","LU1226287792.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654360","title":"百濟神州員工購股計劃完成購買812,149股 涉及4,590名員工","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654360","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654360?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:09","pubTimestamp":1789376940,"startTime":"0","endTime":"0","summary":"9月14日，百济神州(06160.HK)宣布，截至2026年8月31日认购期结束，4,590名合资格雇员根据2018员工购股计划合共购买62,473股美国存托股份，涉及股份数目为812,149股，占已发行股份总数约0.05 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260914/c679883948.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260914/c679883948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU1969619763.USD","ONC","BK4588","LU1251922891.USD","BK1500","BK1161","LU1303224171.USD","LU0588546209.SGD","LU0228659784.USD","LU2328871848.SGD","LU0307460666.USD","BK0239","LU1770034418.SGD","BK1583","688235","LU0828237510.HKD","KURE","BK4139","BK1588","06160","LU1719994722.HKD","BK4585","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651186","title":"百濟神州(06160.HK)：合共6.25萬股美國存托股份由4590名參與者根據2018員工購股計劃購買","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651186","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667651186?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:58","pubTimestamp":1789376313,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0588546209.SGD","LU0828237510.HKD","BK1500","BK1588","LU0228659784.USD","LU0307460666.USD","LU1251922891.USD","LU1770034418.SGD","LU1969619763.USD","06160","LU2328871848.SGD","BK1161","LU1303224171.USD","KURE","LU1719994722.HKD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656624","title":"大行評級丨傑富瑞：康方生物依沃西單抗H-2研究取得正面結果，維持「買入」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656624","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656624?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:59","pubTimestamp":1789372758,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0348766576.USD","KURE","LU0348825331.USD","LU0348783233.USD","BK1574","LU0348767384.USD","LU0348735423.USD","LU0417516738.SGD","LU1720050803.USD","LU2476274720.SGD","LU2488822045.USD","LU0634319403.HKD","LU1961090484.USD","LU0417516902.SGD","IE00B543WZ88.USD","LU0561508036.HKD","LU2778985437.USD","IE00B5MMRT66.SGD","BK1161","LU2399975544.HKD","LU2476274308.USD","LU0540923850.HKD","09926","LU0348784397.USD","LU0348827113.USD","IE00BPRC5H50.USD","LU1794554557.SGD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656089","title":"小摩：康方生物(09926.HK)HARMONi-2總生存期數據強勁 維持「增持」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656089","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656089?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:38","pubTimestamp":1789371481,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0561508036.HKD","KURE","IE00BPRC5H50.USD","LU2476274720.SGD","LU0348825331.USD","LU0348783233.USD","LU0634319403.HKD","LU2476274308.USD","BK1574","IE00B543WZ88.USD","LU1794554557.SGD","09926","LU0348767384.USD","LU0417516738.SGD","LU0417516902.SGD","LU0417516571.SGD","LU0348827113.USD","LU0348766576.USD","LU1961090484.USD","LU1720050803.USD","LU0348735423.USD","LU0348784397.USD","LU2399975544.HKD","LU2778985437.USD","BK1161","LU2488822045.USD","LU0540923850.HKD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667665575","title":"信達生物(01801)出現大手買入6.45萬股，成交價$96.65，涉資623.392萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667665575","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667665575?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:19","pubTimestamp":1789370340,"startTime":"0","endTime":"0","summary":"[大手成交]信达生物(01801)在下午03:19出现大手买入，成交量为6.45万，成交价为港币$96.65，涉资623.392万。至目前为止，股价升3.26%，今日最高价为$97.4，而最低价为$91.7，总成交量为919.039万股，总成交金额港币$8.763亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609144731/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609144731/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2328871848.SGD","01801","LU2097828557.USD","LU1969619763.USD","LU0244354667.USD","KURE","LU2242644610.SGD","LU0607220059.USD","LU0463099449.HKD","LU1188198961.HKD","LU0149534421.HKD","LU2097828631.EUR","LU2097828714.EUR","LU2488822045.USD","BK1589","LU1831875114.USD","BK1161","LU0455707207.USD","HK0000165453.HKD","LU0502904849.HKD","BK1583","LU0326950275.SGD","LU2097828805.USD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655595","title":"《大行》富瑞：康方生物(09926.HK)依沃西單抗單藥總生存期數據良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655595","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667655595?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:06","pubTimestamp":1789369560,"startTime":"0","endTime":"0","summary":"富瑞发表研究报告指，康方生物(09926.HK) 依沃西单抗(Ivonescimab)H-2研究取得正面结果，数据显示，其中期总生存期(OS)具统计学显著性，单药一线治疗PD-L1阳性非小细胞肺癌较帕博利珠单抗(Pembrolizumab)OS显著延长，OS中位数为30.8个月，风险比为0.73，中位随访36个月，对比帕博利珠单抗OS中位数为22.6个月。富瑞指出，康方生物依沃西单抗拥有总生存期优势，数据令人鼓舞，维持“买入”评级及目标价226元。(gc/u)(港股报价延迟最少十五分钟。沽空资料截至 2026-09-14 12:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200424093930528_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200424093930528_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544311/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544311/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0348783233.USD","LU2399975544.HKD","LU0417516738.SGD","LU1720050803.USD","LU2488822045.USD","LU0561508036.HKD","LU1794554557.SGD","IE00B5MMRT66.SGD","LU0348784397.USD","LU0634319403.HKD","LU0348825331.USD","LU0540923850.HKD","LU0348827113.USD","LU0348735423.USD","09926","BK1161","KURE","LU0348767384.USD","IE00BPRC5H50.USD","LU0417516902.SGD","BK1574","LU2476274308.USD","LU1961090484.USD","LU0348766576.USD","LU0417516571.SGD","LU2476274720.SGD","LU2778985437.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667342658","title":"藥明生物(02269)股價上升5.021%，現價港幣$49.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2667342658","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667342658?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:04","pubTimestamp":1789365840,"startTime":"0","endTime":"0","summary":"[上升股]药明生物(02269) 股价在下午02:03比前收市价上升5.021%，现股价为港币$49.36。至目前为止，今日最高价为$49.36，而最低价为$46.42。总成交量为2.124千万股，总成交金额为港币$10.284亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609141471/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609141471/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0819121731.USD","BK1610","BK1141","LU0029874061.USD","02269","LU0516422952.EUR","LU1242518931.SGD","LU0561508036.HKD","LU1880383366.USD","LU0327786744.USD","SG9999002463.SGD","LU3063872942.SGD","LU0043850808.USD","LU0417516738.SGD","LU0181495838.USD","LU1794554557.SGD","LU0572944931.SGD","LU0516422366.SGD","BK1589","LU0516423091.SGD","LU1242518857.USD","LU0516423174.USD","LU1688375341.USD","LU0326950275.SGD","LU0979878070.USD","LU0039217434.USD","LU0348735423.USD","LU0708995583.HKD","LU2039709279.SGD","LU1720050803.USD","LU0348825331.USD","LU0823426308.USD","LU0320764599.SGD","LU0456827905.SGD","LU0307460666.USD","LU0051755006.USD","LU0516422440.USD","LU0588546209.SGD","LU0417516902.SGD","BK1521","LU0128526141.USD","LU0856984785.SGD","LU0140636845.USD","LU0348827113.USD","IE00B0JY6N72.USD","LU0823426480.USD","LU0359202008.SGD","LU0359201612.USD","KURE","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667608630","title":"港股異動 | 創新藥概念股全線走高 WCLC臨床數據重磅催化 機構指回調後配置價值凸顯","url":"https://stock-news.laohu8.com/highlight/detail?id=2667608630","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667608630?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:39","pubTimestamp":1789364389,"startTime":"0","endTime":"0","summary":"消息面上，9月12-15日，2026年世界肺癌大会召开，多项中国创新药临床数据集中亮相，康方生物依沃西单药OS数据、B7H3ADC等成为焦点。中泰证券指出，WCLC集中披露的多项肺癌领域临床进展，进一步验证了中国创新药的临床价值和全球竞争力，或可积极把握创新药回调后的配置机会。机构普遍认为，三季度部分企业新增订单进入收入确认期，基本面有望持续改善。当前医药板块估值27倍PE，低于历史均值，回调后配置价值凸显。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2097828714.EUR","LU1961090484.USD","06978","159992","LU0348827113.USD","LU2476274308.USD","LU0417516738.SGD","LU1188198961.HKD","LU2476274720.SGD","IE00B543WZ88.USD","LU1969619763.USD","LU0326950275.SGD","09926","09969","KCAI","LU2097828805.USD","LU2778985437.USD","BK4588","LNGR","LU0348766576.USD","LU0561508036.HKD","BK1161","HK0000165453.HKD","01801","LU0348784397.USD","LU0348767384.USD","LU0455707207.USD","LU2488822045.USD","MEDX","IE00BZ08YR35.GBP","01530","LU0417516571.SGD","LU0348825331.USD","LU0348735423.USD","LU0607220059.USD","LU0244354667.USD","LU1831875114.USD","LU0634319403.HKD","LU2242644610.SGD","IBBQ","IE00BPRC5H50.USD","VXUS","KURE","BK1589","BK1574","01177","BK1593","LU2097828557.USD","BK1521","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667763172","title":"港股異動 | CRO概念股漲幅居前、凱萊英大漲12%，中報持續驗證行業高景氣，多家公司上調業績指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2667763172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667763172?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:34","pubTimestamp":1789364090,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股涨幅居前，截至发稿，凯莱英涨5.89%，报142.1港元；康龙化成涨4.72%，报28.84港元；泰格医药涨4.64%，报43.32港元；药明生物涨2.30%，报48.08港元。消息面上，国内外CXO公司中报业绩持续验证行业高景气。国内药明康德发布中报，业绩大幅超市场预期，同时大幅上调全年业绩指引。该行表示，看好药明系、康龙化成、凯莱英、泰格医药及金斯瑞。","market":"fut","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495468.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | CRO概念股涨幅居前，中报持续验证行业高景气，多家公司上调业绩指引","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0327786744.USD","LU0516422952.EUR","LU0823426308.USD","LU0819121731.USD","LU0856984785.SGD","LU1880383366.USD","LU0516423091.SGD","LU0348827113.USD","LU0417516738.SGD","LU0516422366.SGD","LU0029874061.USD","LU0572944931.SGD","LU0320764599.SGD","LU0823426480.USD","LU1720050803.USD","LU0051755006.USD","LU0326950275.SGD","KCAI","LU0039217434.USD","LU0359202008.SGD","BK4588","LU0456846285.SGD","LU0456827905.SGD","LU0561508036.HKD","02269","LU0140636845.USD","03347","03759","BK1141","LU0181495838.USD","LU3063872942.SGD","06821","LU0307460666.USD","LU0348825331.USD","SG9999002463.SGD","LU0348735423.USD","BK1610","LU0979878070.USD","LU0128526141.USD","LU0359201612.USD","LU0588546209.SGD","VXUS","KURE","LU1688375341.USD","BK1589","LU0516423174.USD","LU2039709279.SGD","BK1583","BK1521","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667637732","title":"大行評級丨花旗：維持康方生物「買入」評級，HARMONi-2總生存期優效強化ivonescimab差異化優勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2667637732","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667637732?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:24","pubTimestamp":1789363448,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0634319403.HKD","LU0348827113.USD","LU2778985437.USD","IE00B5MMRT66.SGD","LU0348767384.USD","LU0348825331.USD","LU2399975544.HKD","LU0348735423.USD","IE00BPRC5H50.USD","KURE","LU0348783233.USD","LU2488822045.USD","LU1961090484.USD","LU1794554557.SGD","LU0348784397.USD","LU0417516738.SGD","LU0348766576.USD","LU0417516902.SGD","LU0417516571.SGD","LU0540923850.HKD","LU2476274308.USD","IE00B543WZ88.USD","BK1161","09926","LU0561508036.HKD","LU1720050803.USD","BK1574","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667378766","title":"港股早盤低開高走 恒生指數半日上漲0.35% 藥明生物（02269）漲4.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667378766","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667378766?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 12:18","pubTimestamp":1789359482,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股早盘低开高走，截至午间收盘，恒生指数上涨0.35%；国企指数上涨0.4%，恒生科技指数上涨0.17%。医药概念板块表现强势，凯莱英涨10.88%，康龙化成涨5.15%，泰格医药涨7%，药明康德涨4.61%，药明生物涨4.81%。个股方面，联想集团股价扬升，半日涨4.6%。在中国x86服务器市场，第二季度，联想的x86服务器营收同比增长9.0%，以10.5%的市场份额排名第四。长风药业股价冲高回落，半日涨1.16%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991494","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348735423.USD","BK1193","LU1720050803.USD","LU1235295612.USD","LU0049112450.USD","LU0791590937.USD","LU0370786039.SGD","82800","HK0000306701.USD","LU0823426480.USD","00992","LU1046422090.SGD","LU0672654166.SGD","LU0128526141.USD","LU3063872942.SGD","LU0561508036.HKD","LU2242644610.SGD","LU0516422440.USD","LU0543330483.HKD","LU0052750758.USD","LU0348827113.USD","LU0979878070.USD","LU0456827905.SGD","SG9999002463.SGD","IE0003895053.USD","TCHI","LU0417516902.SGD","02269","BK1526","LU0572944931.SGD","02833","BK1141","LU1242518931.SGD","LU1366334578.USD","HHImain","LU2039709279.SGD","07300","LU0128525689.USD","80992","LNVGY","BK1607","LU0327786744.USD","LU1242518857.USD","LU0516423091.SGD","BK1610","02800","LU0029875118.USD","LU0791591158.USD","LU0307460666.USD","03115","LU0572940350.SGD","MCHmain","LU0048580855.USD","LU0039217434.USD","LU0819121731.USD","IE0034224299.USD","HSI","SG9999002562.SGD","BK1589","BK1576","LU0326950275.SGD","03037","83115","LU0516422366.SGD","BK1191","02652","LU0320764599.SGD","LU0972618739.USD","LU1366334651.USD","LU0052756011.USD","LU0359202008.SGD","LU0588546209.SGD","LU0359201612.USD","LU0516422952.EUR","LU0310800965.SGD","LU1785774172.SGD","LU0862451837.USD","03419","LU0572939691.SGD","LU0708995583.HKD","LU0181495838.USD","LU0320764755.SGD","LU0128522157.USD","LU0043850808.USD","WXXWY","LU1688375341.USD","LU0348825331.USD","KURE","LU0029874061.USD","HSTECH","IE0032431581.USD","LU1808992512.USD","LU0456846285.SGD","LU0890818403.SGD","09115","LU0140636845.USD","LU1267930227.SGD","LU0051755006.USD","IE00B0JY6N72.USD","LU0417516738.SGD","LU0823426308.USD","LU0264606111.USD","LU0862451753.SGD","BK1521","HK0000306685.HKD","HK0000320223.HKD","07200","HK0000320264.USD","LU0516423174.USD","LU1880383366.USD","LU0856984785.SGD","LU1794554557.SGD","513600","07500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667632069","title":"《大行》花旗：康方生物(09926.HK)HARMONi-2總生存期優效強化ivonescimab差異化優勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2667632069","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667632069?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 12:14","pubTimestamp":1789359240,"startTime":"0","endTime":"0","summary":"花旗发表研究报告指，康方生物的HARMONi-2中期读数显示，ivonescimab作为PD-L1阳性非小细胞肺癌一线单药治疗，对比pembrolizumab展现有意义的总生存期优效，强化其差异化定位，全球读数仍是关键。该行指出，HARMONi-2在234宗总生存期事件下，ivonescimab的中位总生存期为30.75个月；总生存期获益在PD-L1 TPS > 50%及鳞状非小细胞肺癌，整体存活期获益最为明显，安全性大致相若。该行维持康方生物“买入”评级，目标价171港元不变。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200914151046636_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200914151046636_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544280/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544280/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09926","LU2476274720.SGD","IE00B5MMRT66.SGD","LU0348783233.USD","LU2399975544.HKD","KURE","LU0348766576.USD","BK1574","LU0634319403.HKD","LU0348735423.USD","LU0540923850.HKD","LU0348827113.USD","LU2488822045.USD","LU1961090484.USD","LU0417516738.SGD","BK1161","LU1794554557.SGD","LU0417516902.SGD","LU0561508036.HKD","LU2476274308.USD","LU2778985437.USD","LU0348825331.USD","LU0348784397.USD","LU1720050803.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0348767384.USD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667632490","title":"康方生物(09926.HK)升近半成 里昂：Harmoni-2總生存期更新正面","url":"https://stock-news.laohu8.com/highlight/detail?id=2667632490","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667632490?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:57","pubTimestamp":1789358220,"startTime":"0","endTime":"0","summary":"康方生物今日高开4.49%，最高见96.55元。里昂发表研究报告指，康方生物公布Harmoni-2正面总生存期更新，ivonescimab录得中位OS 30.75个月，对比pembrolizumab 22.57个月，风险比为0.73，显示具统计学意义及临床意义的生存获益。该行认为，该药OS结果符合投资者预期，并为医生提供更多ivonescimab临床表现优于pembrolizumab的证据，尽管风险比不及Harmoni-6的0.66更新吸引；OS数据亦较2025年4月中国标签更新时风险比0.78有所改善。Harmoni-3无进展生存期读出，以及美国FDA于今年下半年就ivonescimab的决定，为后续关键催化剂。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230531145638513_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230531145638513_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544272/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544272/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2476274308.USD","LU1794554557.SGD","LU0348767384.USD","LU1961090484.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU1720050803.USD","LU2778985437.USD","LU0348784397.USD","LU0348827113.USD","09926","BK1161","LU0417516902.SGD","LU0417516571.SGD","LU0634319403.HKD","LU0348825331.USD","LU0417516738.SGD","LU0561508036.HKD","LU0348783233.USD","LU2476274720.SGD","LU2488822045.USD","KURE","LU0540923850.HKD","BK1574","IE00B543WZ88.USD","LU0348766576.USD","LU0348735423.USD","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667632842","title":"港股異動丨康方生物漲近7%，依沃西試驗生存期超過默沙東競品","url":"https://stock-news.laohu8.com/highlight/detail?id=2667632842","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667632842?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:33","pubTimestamp":1789356838,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0561508036.HKD","KURE","IE00BPRC5H50.USD","LU2476274720.SGD","LU0348825331.USD","LU0348783233.USD","LU0634319403.HKD","LU2476274308.USD","BK1574","IE00B543WZ88.USD","LU1794554557.SGD","09926","LU0348767384.USD","LU0417516738.SGD","LU0417516902.SGD","LU0417516571.SGD","LU0348827113.USD","LU0348766576.USD","LU1961090484.USD","LU1720050803.USD","LU0348735423.USD","LU0348784397.USD","LU2399975544.HKD","LU2778985437.USD","BK1161","LU2488822045.USD","LU0540923850.HKD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667083631","title":"醫藥板塊表現強勢 凱萊英（06821）升逾5% 機構制AI製藥商業化風口初步顯現","url":"https://stock-news.laohu8.com/highlight/detail?id=2667083631","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667083631?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:26","pubTimestamp":1789352818,"startTime":"0","endTime":"0","summary":"消息面上，招商证券指出，自2024年以来，AI制药发展速度明显加快，投资规模和项目数量显著增长。跨国药企开始大规模搭建自有AI平台能力，合作模式由单点项目合作转向管线与平台层面深度合作。AI科技巨头入局药物研发领域，依托通用大模型推出面向药物研发的专用AI模型。AI Biotech的合作机会与交易规模持续扩容，即便尚未拥有成熟商业化管线，也获得传统药企青睐。AI制药行业已完成概念验证，正式迈入临床验证阶段，商业化风口初步显现。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991473","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052750758.USD","06821","LU0979878070.USD","LU0516422366.SGD","BK1583","LU0307460666.USD","02269","LU0819121731.USD","LU0128526141.USD","LU1242518857.USD","002821","02359","LU1328615791.USD","BK1610","03759","LU0348766576.USD","03347","LU0359201612.USD","LU0588546209.SGD","SG9999002562.SGD","LU1720050803.USD","LU0417516738.SGD","KURE","LU2242644610.SGD","QTOC","LU2125910500.SGD","BK1515","AGIX","LU0516423174.USD","09939","159938","LU1688375341.USD","BK1141","01477","VTHR","LU0516422440.USD","LU0043850808.USD","AIPO","LU0417516902.SGD","IE00B0JY6N72.USD","CHAT","SG9999002463.SGD","BK1191","LU0326950275.SGD","BK0239","LU1046422090.SGD","LU1242518931.SGD","LU0823426480.USD","LU1880383366.USD","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667463107","title":"康方生物港股走高 其依沃西單藥在試驗中的總生存期超過默沙東競品","url":"https://stock-news.laohu8.com/highlight/detail?id=2667463107","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667463107?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:16","pubTimestamp":1789352160,"startTime":"0","endTime":"0","summary":"南方财经9月14日电，康方生物港股盘初一度上涨5.8%，随后收窄涨幅。此前公司宣布，对比默沙东公司的帕博利珠单抗，其肿瘤免疫药物依沃西显著延长了中位总生存期(OS)至30.8个月，而前者为22.6个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873200884.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873200884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2488822045.USD","LU0561508036.HKD","LU0348735423.USD","LU1961090484.USD","KURE","BK1161","BK1574","LU0417516902.SGD","LU2476274720.SGD","KCAI","BK4588","VXUS","LU2399975544.HKD","BK4585","LU0634319403.HKD","LU0348767384.USD","LU0348827113.USD","LU0417516738.SGD","LU0348825331.USD","LU0348783233.USD","IE00B543WZ88.USD","LU2778985437.USD","IE00B5MMRT66.SGD","LU2476274308.USD","LU0348766576.USD","LU0417516571.SGD","09926","LU0348784397.USD","LU1794554557.SGD","LU0540923850.HKD","IE00BPRC5H50.USD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667863165","title":"康方生物(09926)出現大手賣出6.4萬股，成交價$90.0，涉資576萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667863165","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667863165?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:45","pubTimestamp":1789350300,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在上午09:45出现大手卖出，成交量为6.4万，成交价为港币$90.0，涉资576万。至目前为止，股价跌0.166%，今日最高价为$95.5，而最低价为$90.0，总成交量为364.9万股，总成交金额港币$3.343亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609142177/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609142177/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2399975544.HKD","BK1161","LU1961090484.USD","LU0348784397.USD","LU0634319403.HKD","LU0348827113.USD","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0417516571.SGD","09926","KURE","IE00BPRC5H50.USD","LU1720050803.USD","LU2778985437.USD","LU0417516902.SGD","IE00B543WZ88.USD","LU0348783233.USD","LU0348766576.USD","LU0417516738.SGD","LU2488822045.USD","LU0348735423.USD","LU0348825331.USD","LU0561508036.HKD","BK1574","LU2476274720.SGD","LU1794554557.SGD","LU0348767384.USD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}